Home Applications 022334 Application 022334
Type NDA
Sponsor NOVARTIS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 AFINITOR EVEROLIMUS TABLET;ORAL 5MG Yes Yes 002 AFINITOR EVEROLIMUS TABLET;ORAL 10MG Yes No 003 AFINITOR EVEROLIMUS TABLET;ORAL 2.5MG Yes No 004 AFINITOR EVEROLIMUS TABLET;ORAL 7.5MG Yes No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N022334-001 AFINITOR EVEROLIMUS 5MG TABLET / ORAL AB RLD, RS 2009-03-30 N022334-002 AFINITOR EVEROLIMUS 10MG TABLET / ORAL AB RLD 2009-03-30 N022334-003 AFINITOR EVEROLIMUS 2.5MG TABLET / ORAL AB RLD 2010-07-09 N022334-004 AFINITOR EVEROLIMUS 7.5MG TABLET / ORAL AB RLD 2012-03-30
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Orange Book patents# Current patent rows page 1 of 1 · 12 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N022334-001 8410131 2025-11-01 U-1368 2013-04-02 N022334-001 8410131*PED 2026-05-01 Pediatric extension N022334-001 9006224 2028-07-01 U-1681 2015-04-20 N022334-002 8410131 2025-11-01 U-1368 2013-04-02 N022334-002 8410131*PED 2026-05-01 Pediatric extension N022334-002 9006224 2028-07-01 U-1681 2015-04-20 N022334-003 8410131 2025-11-01 U-1368 2013-04-02 N022334-003 8410131*PED 2026-05-01 Pediatric extension N022334-003 9006224 2028-07-01 U-1681 2015-04-20 N022334-004 8410131 2025-11-01 U-1368 2013-04-02 N022334-004 8410131*PED 2026-05-01 Pediatric extension N022334-004 9006224 2028-07-01 U-1681 2015-04-20
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 168 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N022334-001 AFINITOR 5MG TABLET / ORAL AB RLD, RS 2009-03-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022334-002 AFINITOR 10MG TABLET / ORAL AB RLD 2009-03-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022334-003 AFINITOR 2.5MG TABLET / ORAL AB RLD 2010-07-09 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022334-004 AFINITOR 7.5MG TABLET / ORAL AB RLD 2012-03-30 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N022334-001 AFINITOR 5MG TABLET / ORAL AB RLD, RS 2009-03-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022334-002 AFINITOR 10MG TABLET / ORAL AB RLD 2009-03-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022334-003 AFINITOR 2.5MG TABLET / ORAL AB RLD 2010-07-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022334-004 AFINITOR 7.5MG TABLET / ORAL AB RLD 2012-03-30 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022334-001 AFINITOR 5MG TABLET / ORAL AB RLD, RS 2009-03-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022334-002 AFINITOR 10MG TABLET / ORAL AB RLD 2009-03-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022334-003 AFINITOR 2.5MG TABLET / ORAL AB RLD 2010-07-09 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022334-004 AFINITOR 7.5MG TABLET / ORAL AB RLD 2012-03-30 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022334-001 AFINITOR 5MG TABLET / ORAL AB RLD, RS 2009-03-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022334-002 AFINITOR 10MG TABLET / ORAL AB RLD 2009-03-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022334-003 AFINITOR 2.5MG TABLET / ORAL AB RLD 2010-07-09 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022334-004 AFINITOR 7.5MG TABLET / ORAL AB RLD 2012-03-30 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022334-001 AFINITOR 5MG TABLET / ORAL AB RLD, RS 2009-03-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022334-002 AFINITOR 10MG TABLET / ORAL AB RLD 2009-03-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022334-003 AFINITOR 2.5MG TABLET / ORAL AB RLD 2010-07-09 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022334-004 AFINITOR 7.5MG TABLET / ORAL AB RLD 2012-03-30 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022334-001 AFINITOR 5MG TABLET / ORAL AB RLD, RS 2009-03-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022334-002 AFINITOR 10MG TABLET / ORAL AB RLD 2009-03-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022334-003 AFINITOR 2.5MG TABLET / ORAL AB RLD 2010-07-09 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022334-004 AFINITOR 7.5MG TABLET / ORAL AB RLD 2012-03-30 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022334-001 AFINITOR 5MG TABLET / ORAL AB RLD, RS 2009-03-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022334-002 AFINITOR 10MG TABLET / ORAL AB RLD 2009-03-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022334-003 AFINITOR 2.5MG TABLET / ORAL AB RLD 2010-07-09 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022334-004 AFINITOR 7.5MG TABLET / ORAL AB RLD 2012-03-30 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022334-001 AFINITOR 5MG TABLET / ORAL AB RLD, RS 2009-03-30 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022334-002 AFINITOR 10MG TABLET / ORAL AB RLD 2009-03-30 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022334-003 AFINITOR 2.5MG TABLET / ORAL AB RLD 2010-07-09 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022334-004 AFINITOR 7.5MG TABLET / ORAL AB RLD 2012-03-30 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022334-001 AFINITOR 5MG TABLET / ORAL AB RLD, RS 2009-03-30 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022334-002 AFINITOR 10MG TABLET / ORAL AB RLD 2009-03-30 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022334-003 AFINITOR 2.5MG TABLET / ORAL AB RLD 2010-07-09 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022334-004 AFINITOR 7.5MG TABLET / ORAL AB RLD 2012-03-30 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022334-001 AFINITOR 5MG TABLET / ORAL AB RLD, RS 2009-03-30 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022334-002 AFINITOR 10MG TABLET / ORAL AB RLD 2009-03-30 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022334-003 AFINITOR 2.5MG TABLET / ORAL AB RLD 2010-07-09 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022334-004 AFINITOR 7.5MG TABLET / ORAL AB RLD 2012-03-30 d8e5a09893c0…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 154 observed states.
Observed Orange Book patent history# Patent history page 1 of 23 · 888 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-08-18 06:07:40 2026-07 N022334-001 8410131 2025-11-01 U-1368 2013-04-02 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022334-001 8410131*PED 2026-05-01 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022334-001 9006224 2028-07-01 U-1681 2015-04-20 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022334-002 8410131 2025-11-01 U-1368 2013-04-02 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022334-002 8410131*PED 2026-05-01 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022334-002 9006224 2028-07-01 U-1681 2015-04-20 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022334-003 8410131 2025-11-01 U-1368 2013-04-02 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022334-003 8410131*PED 2026-05-01 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022334-003 9006224 2028-07-01 U-1681 2015-04-20 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022334-004 8410131 2025-11-01 U-1368 2013-04-02 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022334-004 8410131*PED 2026-05-01 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022334-004 9006224 2028-07-01 U-1681 2015-04-20 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N022334-001 8410131 2025-11-01 U-1368 2013-04-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022334-001 8410131*PED 2026-05-01 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022334-001 9006224 2028-07-01 U-1681 2015-04-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022334-002 8410131 2025-11-01 U-1368 2013-04-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022334-002 8410131*PED 2026-05-01 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022334-002 9006224 2028-07-01 U-1681 2015-04-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022334-003 8410131 2025-11-01 U-1368 2013-04-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022334-003 8410131*PED 2026-05-01 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022334-003 9006224 2028-07-01 U-1681 2015-04-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022334-004 8410131 2025-11-01 U-1368 2013-04-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022334-004 8410131*PED 2026-05-01 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022334-004 9006224 2028-07-01 U-1681 2015-04-20 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022334-001 8410131 2025-11-01 U-1368 2013-04-02 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022334-001 8410131*PED 2026-05-01 Pediatric extension 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022334-001 9006224 2028-07-01 U-1681 2015-04-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022334-002 8410131 2025-11-01 U-1368 2013-04-02 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022334-002 8410131*PED 2026-05-01 Pediatric extension 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022334-002 9006224 2028-07-01 U-1681 2015-04-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022334-003 8410131 2025-11-01 U-1368 2013-04-02 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022334-003 8410131*PED 2026-05-01 Pediatric extension 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022334-003 9006224 2028-07-01 U-1681 2015-04-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022334-004 8410131 2025-11-01 U-1368 2013-04-02 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022334-004 8410131*PED 2026-05-01 Pediatric extension 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022334-004 9006224 2028-07-01 U-1681 2015-04-20 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022334-001 8410131 2025-11-01 U-1368 2013-04-02 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022334-001 8410131*PED 2026-05-01 Pediatric extension 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022334-001 9006224 2028-07-01 U-1681 2015-04-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022334-002 8410131 2025-11-01 U-1368 2013-04-02 6a471c1ec25d…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 4 · 144 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 36 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0078-0566 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current 0078-0566 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current 0078-0566 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current 0078-0566 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current 0078-0566 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current 0078-0566 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current 0078-0566 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current 0078-0566 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current 0078-0566 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current 0078-0567 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current 0078-0567 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current 0078-0567 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current 0078-0567 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current 0078-0567 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current 0078-0567 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current 0078-0567 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current 0078-0567 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current 0078-0567 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current 0078-0594 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current 0078-0594 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current 0078-0594 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current 0078-0594 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current 0078-0594 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current 0078-0594 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current 0078-0594 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current 0078-0594 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current 0078-0594 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current 0078-0620 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current 0078-0620 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current 0078-0620 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current 0078-0620 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current 0078-0620 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current 0078-0620 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current 0078-0620 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current 0078-0620 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current 0078-0620 Afinitor everolimus Novartis Pharmaceuticals Corporation NDA Current